alnuctamab
bms
['bet', 'mmsm', 'equate', 'multiple myeloma', '#162', 'alnuctamab', '2019', 'cc-93269', 'bms', 'effector ', 'valent ,(-prevalent)']
#ash22 #mmsm alnuctamab another bispecific,promising results in early studies dor seems to be encouraging.orr seems similar to other agents-infections seem to be better though short follow up
well done presentation with very reasonablediscussion&amp;responses by 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities